DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Fundamental Analysis & Valuation
NASDAQ:DHCNL • US25525P3055
Current stock price
18.2 USD
+0.1 (+0.55%)
Last:
This DHCNL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DHCNL Profitability Analysis
1.1 Basic Checks
- In the past year DHCNL has reported negative net income.
- In the past year DHCNL has reported a negative cash flow from operations.
- In the past 5 years DHCNL reported 4 times negative net income.
- In multiple years DHCNL reported negative operating cash flow during the last 5 years.
1.2 Ratios
- With a Return On Assets value of -6.56%, DHCNL is not doing good in the industry: 85.25% of the companies in the same industry are doing better.
- The Return On Equity of DHCNL (-17.16%) is worse than 81.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.56% | ||
| ROE | -17.16% | ||
| ROIC | N/A |
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of DHCNL (18.11%) is worse than 93.44% of its industry peers.
- In the last couple of years the Gross Margin of DHCNL has declined.
- DHCNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.11% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
2. DHCNL Health Analysis
2.1 Basic Checks
- DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, DHCNL has more shares outstanding
- The number of shares outstanding for DHCNL has been increased compared to 5 years ago.
- Compared to 1 year ago, DHCNL has an improved debt to assets ratio.
2.2 Solvency
- DHCNL has an Altman-Z score of 0.37. This is a bad value and indicates that DHCNL is not financially healthy and even has some risk of bankruptcy.
- DHCNL has a Altman-Z score of 0.37. This is comparable to the rest of the industry: DHCNL outperforms 46.72% of its industry peers.
- A Debt/Equity ratio of 1.44 is on the high side and indicates that DHCNL has dependencies on debt financing.
- DHCNL's Debt to Equity ratio of 1.44 is in line compared to the rest of the industry. DHCNL outperforms 42.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.37 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
- A Current Ratio of 1.56 indicates that DHCNL should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.56, DHCNL is in the better half of the industry, outperforming 76.23% of the companies in the same industry.
- A Quick Ratio of 1.56 indicates that DHCNL should not have too much problems paying its short term obligations.
- DHCNL's Quick ratio of 1.56 is fine compared to the rest of the industry. DHCNL outperforms 77.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.56 |
3. DHCNL Growth Analysis
3.1 Past
- DHCNL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
- Looking at the last year, DHCNL shows a small growth in Revenue. The Revenue has grown by 2.84% in the last year.
- DHCNL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.18% yearly.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
3.2 Future
- Based on estimates for the next years, DHCNL will show a very strong growth in Earnings Per Share. The EPS will grow by 26.15% on average per year.
- DHCNL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.07% yearly.
EPS Next Y50.42%
EPS Next 2Y26.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.21%
Revenue Next 2Y4.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. DHCNL Valuation Analysis
4.1 Price/Earnings Ratio
- DHCNL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year DHCNL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DHCNL is valued more expensive than 90.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.76 |
4.3 Compensation for Growth
- DHCNL's earnings are expected to grow with 26.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.15%
EPS Next 3YN/A
5. DHCNL Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.55%, DHCNL is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 7.83, DHCNL's dividend is way lower than its industry peers. On top of this 90.16% of the companies listed in the same industry pay a better dividend than DHCNL!
- Compared to an average S&P500 Dividend Yield of 1.83, DHCNL's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
5.2 History
- The dividend of DHCNL decreases each year by -25.96%.
- DHCNL has been paying a dividend for over 5 years, so it has already some track record.
- The dividend of DHCNL decreased recently.
Dividend Growth(5Y)-25.96%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- DHCNL has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.38%
EPS Next 2Y26.15%
EPS Next 3YN/A
DHCNL Fundamentals: All Metrics, Ratios and Statistics
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46
NASDAQ:DHCNL (4/10/2026, 8:17:29 PM)
18.2
+0.1 (+0.55%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners79.63%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.41B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target18.83 (3.46%)
Short Float %0.02%
Short Ratio1.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-13 2026-02-13 (0.390625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)9.48%
PT rev (3m)-7.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)1.82%
EPS NY rev (3m)6.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.49%
Revenue NY rev (1m)-1.31%
Revenue NY rev (3m)-2.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.87 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.65 | ||
| P/tB | 2.65 | ||
| EV/EBITDA | 28.76 |
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.56% | ||
| ROE | -17.16% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 18.11% | ||
| FCFM | N/A |
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.3 | ||
| Cap/Depr | 56.06% | ||
| Cap/Sales | 9.55% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.56 | ||
| Altman-Z | 0.37 |
F-Score6
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y50.42%
EPS Next 2Y26.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year1.21%
Revenue Next 2Y4.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1823.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 / DHCNL Fundamental Analysis FAQ
What is the ChartMill fundamental rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?
ChartMill assigns a fundamental rating of 2 / 10 to DHCNL.
What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?
ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL). This can be considered as Overvalued.
What is the profitability of DHCNL stock?
DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) has a profitability rating of 0 / 10.
What is the financial health of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) stock?
The financial health rating of DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) is 3 / 10.